ARCHIVES

As ImClone Investigation Continues, FDA Combines Drugs, Biologics Review; Memo Describes “Lengthy Process” That Led To FDA Decision; Oncology Community Praises FDA Move

This article is from The Cancer Letter archive.

Vol. 28 No. 33 | September 13, 2002

Download PDF Visit The Full Archive

Related Articles

FDA Designates Zometa For Priority Review.

November 30, 2001

UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant.

August 31, 2001

In Brief: Breast Cancer Coalition Delivers 175,000 Letters To Congress; IL Cancer Council Has New Name

October 11, 1991

NCA Okays Only A committee For Centers, Not New Division

May 29, 1987

NCI Forms Task Force To Examine Marin County Breast Cancer Incidence

November 15, 2002

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980